195 related articles for article (PubMed ID: 8297198)
1. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors.
García Rodríguez LA; Williams R; Derby LE; Dean AD; Jick H
Arch Intern Med; 1994 Feb; 154(3):311-6. PubMed ID: 8297198
[TBL] [Abstract][Full Text] [Related]
2. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs.
Pérez Gutthann S; García Rodríguez LA
Epidemiology; 1993 Nov; 4(6):496-501. PubMed ID: 8268277
[TBL] [Abstract][Full Text] [Related]
3. The role of non-steroidal anti-inflammatory drugs in acute liver injury.
García Rodríguez LA; Pérez Gutthann S; Walker AM; Lueck L
BMJ; 1992 Oct; 305(6858):865-8. PubMed ID: 1422399
[TBL] [Abstract][Full Text] [Related]
4. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study.
Gulmez SE; Unal US; Lassalle R; Chartier A; Grolleau A; Moore N
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1174-1181. PubMed ID: 30112779
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.
Lacroix I; Lapeyre-Mestre M; Bagheri H; Pathak A; Montastruc JL; ;
Fundam Clin Pharmacol; 2004 Apr; 18(2):201-6. PubMed ID: 15066135
[TBL] [Abstract][Full Text] [Related]
6. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs.
Walker AM
Arthritis Rheum; 1997 Feb; 40(2):201-8. PubMed ID: 9041931
[TBL] [Abstract][Full Text] [Related]
7. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis.
Svanström H; Lund M; Melbye M; Pasternak B
Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):885-893. PubMed ID: 29797447
[TBL] [Abstract][Full Text] [Related]
8. Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.
Moore N; Gulmez SE; Larrey D; Pageaux GP; Lignot S; Lassalle R; Jové J; Pariente A; Blin P; Bénichou J; Bégaud B
Pharmacoepidemiol Drug Saf; 2013 Feb; 22(2):160-7. PubMed ID: 23166053
[TBL] [Abstract][Full Text] [Related]
9. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
[TBL] [Abstract][Full Text] [Related]
10. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patients.
Cao YL; Tian ZG; Wang F; Li WG; Cheng DY; Yang YF; Gao HM
World J Gastroenterol; 2014 Oct; 20(38):13956-65. PubMed ID: 25320533
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
Griffin MR
Am J Med; 1998 Mar; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
[TBL] [Abstract][Full Text] [Related]
13. Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study.
Lafrance JP; Miller DR
Am J Kidney Dis; 2012 Jul; 60(1):82-9. PubMed ID: 22503390
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.
Manoukian AV; Carson JL
Drug Saf; 1996 Jul; 15(1):64-71. PubMed ID: 8862964
[TBL] [Abstract][Full Text] [Related]
15. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study.
Hsu CC; Wang H; Hsu YH; Chuang SY; Huang YW; Chang YK; Liu JS; Hsiung CA; Tsai HJ
Hypertension; 2015 Sep; 66(3):524-33. PubMed ID: 26169048
[TBL] [Abstract][Full Text] [Related]
16. Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.
Lin TC; Solomon DH; Tedeschi SK; Yoshida K; Kao Yang YH
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079568
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure.
Pérez Gutthann S; García Rodríguez LA; Raiford DS; Duque Oliart A; Ris Romeu J
Arch Intern Med; 1996 Nov; 156(21):2433-9. PubMed ID: 8944736
[TBL] [Abstract][Full Text] [Related]
18. Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW;
Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797
[TBL] [Abstract][Full Text] [Related]
19. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.
Donati M; Conforti A; Lenti MC; Capuano A; Bortolami O; Motola D; Moretti U; Vannacci A; Rafaniello C; Vaccheri A; Arzenton E; Bonaiuti R; Sportiello L; Leone R;
Br J Clin Pharmacol; 2016 Jul; 82(1):238-48. PubMed ID: 26991794
[TBL] [Abstract][Full Text] [Related]
20. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts.
Wong AY; MacKenna B; Morton CE; Schultze A; Walker AJ; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Forbes H; Eggo RM; Parry J; Hester F; Harper S; Evans SJ; Smeeth L; Douglas IJ; Goldacre B;
Ann Rheum Dis; 2021 Jul; 80(7):943-951. PubMed ID: 33478953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
